Identification Tag Reader System for Medical Devices
Summary
The European Patent Office published patent application EP4275718A2 for Bayer HealthCare LLC covering an identification tag reader system. The invention, filed by inventors Christopher Capone and Jaroslaw Wlodarczyk, is classified under IPC A61M 5/145 and A61M 5/168 relating to medical device infusion systems. The patent designates all EU member states and additional European countries.
What changed
The EPO published patent application EP4275718A2 for Bayer HealthCare LLC's identification tag reader system used in medical devices, specifically infusion systems (A61M classification). The system appears to involve technology for reading identification tags on medical devices to verify authenticity or track usage. This is a standard patent publication notice with no regulatory requirements.
No compliance actions are required from this patent publication. Entities manufacturing or using medical infusion devices may wish to monitor this patent to understand potential intellectual property implications for their products. The publication is informational and does not impose any regulatory obligations or deadlines.
Source document (simplified)
IDENTIFICATION TAG READER SYSTEM
Publication EP4275718A2 Kind: A2 Mar 25, 2026
Applicants
Bayer HealthCare LLC
Inventors
Capone, Christopher, Wlodarczyk, Jaroslaw
IPC Classifications
A61M 5/145 20060101AFI20240104BHEP A61M 5/168 20060101ALI20240104BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Medical Devices (A61M) publishes new changes.